Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1998 Jun 15;26(12):2886–2890. doi: 10.1093/nar/26.12.2886

TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomer.

A Garbesi 1, F Hamy 1, M Maffini 1, G Albrecht 1, T Klimkait 1
PMCID: PMC147661  PMID: 9611232

Abstract

An oligoribonucleotide, corresponding to the Tat-interactive top half of the HIV-1 TAR RNA stem-loop, was synthesized in both the natural D- and the enantiomeric L-configurations. The affinity of Tat for the two RNAs, assessed by competition binding experiments, was found to be identical and is reduced 10-fold for both, upon replacement of the critical bulge residue U23 with cytidine. It is suggested that this interaction of the flexible Tat protein depends strongly upon the tertiary structure of a binding pocket within TAR, but not upon its handedness, and may be described by a 'hand-in-mitten' model.

Full Text

The Full Text of this article is available as a PDF (141.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aboul-ela F., Karn J., Varani G. Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. Nucleic Acids Res. 1996 Oct 15;24(20):3974–3981. doi: 10.1093/nar/24.20.3974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aboul-ela F., Karn J., Varani G. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. J Mol Biol. 1995 Oct 20;253(2):313–332. doi: 10.1006/jmbi.1995.0555. [DOI] [PubMed] [Google Scholar]
  3. Asseline U., Hau J. F., Czernecki S., Le Diguarher T., Perlat M. C., Valery J. M., Thuong N. T. Synthesis and physicochemical properties of oligonucleotides built with either alpha-L or beta-L nucleotides units and covalently linked to an acridine derivative. Nucleic Acids Res. 1991 Aug 11;19(15):4067–4074. doi: 10.1093/nar/19.15.4067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brother M. B., Chang H. K., Lisziewicz J., Su D., Murty L. C., Ensoli B. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys. Virology. 1996 Aug 1;222(1):252–256. doi: 10.1006/viro.1996.0416. [DOI] [PubMed] [Google Scholar]
  5. Churcher M. J., Lamont C., Hamy F., Dingwall C., Green S. M., Lowe A. D., Butler J. G., Gait M. J., Karn J. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J Mol Biol. 1993 Mar 5;230(1):90–110. doi: 10.1006/jmbi.1993.1128. [DOI] [PubMed] [Google Scholar]
  6. Damha M. J., Giannaris P. A., Marfey P. Antisense L/D-oligodeoxynucleotide chimeras: nuclease stability, base-pairing properties, and activity at directing ribonuclease H. Biochemistry. 1994 Jun 28;33(25):7877–7885. doi: 10.1021/bi00191a015. [DOI] [PubMed] [Google Scholar]
  7. Damha M. J., Ogilvie K. K. Oligoribonucleotide synthesis. The silyl-phosphoramidite method. Methods Mol Biol. 1993;20:81–114. doi: 10.1385/0-89603-281-7:81. [DOI] [PubMed] [Google Scholar]
  8. Dingwall C., Ernberg I., Gait M. J., Green S. M., Heaphy S., Karn J., Lowe A. D., Singh M., Skinner M. A., Valerio R. Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci U S A. 1989 Sep;86(18):6925–6929. doi: 10.1073/pnas.86.18.6925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ensoli B., Barillari G., Salahuddin S. Z., Gallo R. C., Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 1990 May 3;345(6270):84–86. doi: 10.1038/345084a0. [DOI] [PubMed] [Google Scholar]
  10. Faraj A., Agrofoglio L. A., Wakefield J. K., McPherson S., Morrow C. D., Gosselin G., Mathe C., Imbach J. L., Schinazi R. F., Sommadossi J. P. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogs. Antimicrob Agents Chemother. 1994 Oct;38(10):2300–2305. doi: 10.1128/aac.38.10.2300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fujimori S., Iwanami N., Shudo K., Hashimoto Y. Enantio- and meso-oligodeoxyribonucleotides. Nucleic Acids Symp Ser. 1991;(25):143–144. [PubMed] [Google Scholar]
  12. Garbesi A., Capobianco M. L., Colonna F. P., Tondelli L., Arcamone F., Manzini G., Hilbers C. W., Aelen J. M., Blommers M. J. L-DNAs as potential antimessenger oligonucleotides: a reassessment. Nucleic Acids Res. 1993 Sep 11;21(18):4159–4165. doi: 10.1093/nar/21.18.4159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hamy F., Felder E. R., Heizmann G., Lazdins J., Aboul-ela F., Varani G., Karn J., Klimkait T. An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3548–3553. doi: 10.1073/pnas.94.8.3548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Huq I., Wang X., Rana T. M. Specific recognition of HIV-1 TAR RNA by a D-Tat peptide. Nat Struct Biol. 1997 Nov;4(11):881–882. doi: 10.1038/nsb1197-881. [DOI] [PubMed] [Google Scholar]
  15. Li C. J., Friedman D. J., Wang C., Metelev V., Pardee A. B. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science. 1995 Apr 21;268(5209):429–431. doi: 10.1126/science.7716549. [DOI] [PubMed] [Google Scholar]
  16. Lisziewicz J., Sun D., Smythe J., Lusso P., Lori F., Louie A., Markham P., Rossi J., Reitz M., Gallo R. C. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8000–8004. doi: 10.1073/pnas.90.17.8000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Loret E. P., Georgel P., Johnson W. C., Jr, Ho P. S. Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9734–9738. doi: 10.1073/pnas.89.20.9734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Morvan F., Génu C., Rayner B., Gosselin G., Imbach J. L. Sugar modified oligonucleotides. III (1). Synthesis, nuclease resistance and base pairing properties of alpha- and beta-L-octathymidylates. Biochem Biophys Res Commun. 1990 Oct 30;172(2):537–543. doi: 10.1016/0006-291x(90)90706-s. [DOI] [PubMed] [Google Scholar]
  19. Nolte A., Klussmann S., Bald R., Erdmann V. A., Fürste J. P. Mirror-design of L-oligonucleotide ligands binding to L-arginine. Nat Biotechnol. 1996 Sep;14(9):1116–1119. doi: 10.1038/nbt0996-1116. [DOI] [PubMed] [Google Scholar]
  20. Pritchard C. E., Grasby J. A., Hamy F., Zacharek A. M., Singh M., Karn J., Gait M. J. Methylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus tat and rev proteins. Nucleic Acids Res. 1994 Jul 11;22(13):2592–2600. doi: 10.1093/nar/22.13.2592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rosen C. A., Pavlakis G. N. Tat and Rev: positive regulators of HIV gene expression. AIDS. 1990 Jun;4(6):499–509. [PubMed] [Google Scholar]
  22. Schneider D. J., Feigon J., Hostomsky Z., Gold L. High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry. 1995 Jul 25;34(29):9599–9610. doi: 10.1021/bi00029a037. [DOI] [PubMed] [Google Scholar]
  23. Shapiro J. T., Leng M., Felsenfeld G. Deoxyribonucleic acid-polylysine complexes. Structure and nucleotide specificity. Biochemistry. 1969 Aug;8(8):3219–3232. doi: 10.1021/bi00836a014. [DOI] [PubMed] [Google Scholar]
  24. Spadari S., Maga G., Focher F., Ciarrocchi G., Manservigi R., Arcamone F., Capobianco M., Carcuro A., Colonna F., Iotti S. L-thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth. J Med Chem. 1992 Oct 30;35(22):4214–4220. doi: 10.1021/jm00100a029. [DOI] [PubMed] [Google Scholar]
  25. Sullenger B. A., Gallardo H. F., Ungers G. E., Gilboa E. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell. 1990 Nov 2;63(3):601–608. doi: 10.1016/0092-8674(90)90455-n. [DOI] [PubMed] [Google Scholar]
  26. Tao J., Frankel A. D. Specific binding of arginine to TAR RNA. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2723–2726. doi: 10.1073/pnas.89.7.2723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Verri A., Focher F., Priori G., Gosselin G., Imbach J. L., Capobianco M., Garbesi A., Spadari S. Lack of enantiospecificity of human 2'-deoxycytidine kinase: relevance for the activation of beta-L-deoxycytidine analogs as antineoplastic and antiviral agents. Mol Pharmacol. 1997 Jan;51(1):132–138. doi: 10.1124/mol.51.1.132. [DOI] [PubMed] [Google Scholar]
  28. Weeks K. M., Crothers D. M. RNA binding assays for Tat-derived peptides: implications for specificity. Biochemistry. 1992 Oct 27;31(42):10281–10287. doi: 10.1021/bi00157a015. [DOI] [PubMed] [Google Scholar]
  29. Weeks K. M., Crothers D. M. RNA recognition by Tat-derived peptides: interaction in the major groove? Cell. 1991 Aug 9;66(3):577–588. doi: 10.1016/0092-8674(81)90020-9. [DOI] [PubMed] [Google Scholar]
  30. Wu-Baer F., Sigman D., Gaynor R. B. Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat. Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7153–7157. doi: 10.1073/pnas.92.16.7153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wu A. F., Chargaff E. L-uridine: synthesis and behavior as enzyme substrate. Proc Natl Acad Sci U S A. 1969 Aug;63(4):1222–1226. doi: 10.1073/pnas.63.4.1222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wu T., Ogilvie K. K., Pon R. T. Prevention of chain cleavage in the chemical synthesis of 2'-silylated oligoribonucleotides. Nucleic Acids Res. 1989 May 11;17(9):3501–3517. doi: 10.1093/nar/17.9.3501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yamaguchi T., Saneyoshi M. Synthetic nucleosides and nucleotides. XXI. On the synthesis and biological evaluations of 2'-deoxy-alpha-D-ribofuranosyl nucleosides and nucleotides. Chem Pharm Bull (Tokyo) 1984 Apr;32(4):1441–1450. doi: 10.1248/cpb.32.1441. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES